| Literature DB >> 34790415 |
Jin Yang1, Yue Qu2, Boai Li1, Zelong Zhong1, Liukun Shi1, Xiaofeng Tian1, Rui Wang1, Dan Xu3, Yufeng Liu1.
Abstract
PURPOSE: To analyze the epidemiological characteristics of inpatients who underwent surgery for glaucoma at Tianjin Eye Hospital from 2013 to 2017.Entities:
Year: 2021 PMID: 34790415 PMCID: PMC8592764 DOI: 10.1155/2021/3628481
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1The trend of average age of glaucoma patients from 2013 to 2017 (years). PACG = primary angle-closure glaucoma, POAG = primary open-angle glaucoma, SG = secondary glaucoma, MG = mixed glaucoma, and CG = congenital glaucoma.
Distribution of glaucoma types from 2013 to 2017.
| Year | PACG | POAG | CG | SG | MG | Postoperative complications | Total |
|---|---|---|---|---|---|---|---|
| 2013 | 411 (59.5%) | 50 (7.2%) | 9 (1.3%) | 201 (29.1%) | 4 (0.6%) | 16 (2.3%) | 691 (100.0%) |
| 2014 | 421 (56.2%) | 56 (7.5%) | 8 (1.1%) | 211 (28.2%) | 12 (1.6%) | 41 (5.5%) | 749 (100.0%) |
| 2015 | 613 (59.1%) | 56 (5.4%) | 10 (1.0%) | 293 (28.3%) | 20 (1.9%) | 45 (4.3%) | 1037 (100.0%) |
| 2016 | 667 (66.0%) | 87 (8.6%) | 10 (1.0%) | 209 (20.7%) | 2 (0.2%) | 35 (3.5%) | 1010 (100.0%) |
| 2017 | 618 (58.7%) | 96 (9.1%) | 4 (0.4%) | 245 (23.3%) | 12 (1.1%) | 77 (7.3%) | 1052 (100.0%) |
| Total | 2730 (60.1%) | 345 (7.6%) | 41 (0.9%) | 1159 (25.5%) | 50 (1.1%) | 214 (4.7%) | 4539 (100.0%) |
PACG = primary angle-closure glaucoma, POAG = primary open-angle glaucoma, CG = congenital glaucoma, SG = secondary glaucoma, and MG = mixed glaucoma.
Figure 2Clinical stages of acute angle-closure glaucoma.
Figure 3Annual distribution of the different types of secondary glaucoma.
Univariate analysis of different factors in different glaucoma types.
| PACG | POAG | CG | SG | MG | Postoperative complications | Total |
|
| |
|---|---|---|---|---|---|---|---|---|---|
| Sex | 468.8 | <0.001 | |||||||
| Male | 838 | 228 | 22 | 749 | 25 | 85 | 1947 | ||
| Female | 1892 | 117 | 19 | 410 | 25 | 129 | 2592 | ||
| Hypertension | 915 | 99 | 0 | 295 | 13 | 48 | 1370 | 51.3 | <0.001 |
| 33.5% | 28.7% | 0.0% | 25.5% | 26.0% | 22.4% | 30.2% | |||
| Diabetes | 322 | 65 | 0 | 239 | 7 | 22 | 655 | 66.7 | <0.001 |
| 11.8% | 18.8% | 0.0% | 20.6% | 14.0% | 10.3% | 14.4% | |||
| Heart disease | 347 | 41 | 0 | 91 | 2 | 19 | 500 | 28.7 | <0.001 |
| 12.7% | 11.9% | 0.0% | 7.9% | 4.0% | 8.9% | 11.0% | |||
| Cerebrovascular disease | 107 | 15 | 0 | 40 | 0 | 5 | 167 | 5.6 | 0.346 |
| 3.9% | 4.3% | 0.0% | 3.5% | 0.0% | 2.3% | 3.7% | |||
| Family history | 159 | 10 | 1 | 7 | 2 | 11 | 190 | 57.6 | <0.001 |
| 5.8% | 2.9% | 2.4% | 0.6% | 4.0% | 5.1% | 4.2% |
PACG = primary angle-closure glaucoma, POAG = primary open-angle glaucoma, CG = congenital glaucoma, SG = secondary glaucoma, and MG = mixed glaucoma.
Distribution of types of antiglaucoma surgery from 2013 to 2017.
| 2013 | 2014 | 2015 | 2016 | 2017 | Total | |
|---|---|---|---|---|---|---|
| PACG | ||||||
| Phaco | 90 (21.9%) | 98 (23.3%) | 130 (21.2%) | 128 (19.2%) | 145 (23.5%) | 591 (21.6%) |
| Phaco-trab | 129 (31.4%) | 168 (39.9%) | 223 (36.4%) | 299 (44.8%) | 324 (52.4%) | 1143 (41.9%) |
| Trab | 171 (41.6%) | 120 (28.5%) | 203 (33.1%) | 204 (30.6%) | 106 (17.2%) | 804 (29.5%) |
| LPI | 5 (1.2%) | 18 (4.3%) | 32 (5.2%) | 7 (1.0%) | 10 (1.6%) | 72 (2.6%) |
| TSCP | 16 (3.9%) | 17 (4.0%) | 25 (4.1%) | 29 (4.3%) | 33 (5.3%) | 120 (4.4%) |
| POAG | ||||||
| Phaco-trab | 29 (58.0%) | 31 (55.4%) | 34 (60.7%) | 43 (49.4%) | 68 (70.8%) | 205 (59.4%) |
| Trab | 17 (34.0%) | 17 (30.4%) | 20 (35.7%) | 35 (40.2%) | 24 (25.0%) | 113 (32.8%) |
| TSCP | 4 (8.0%) | 4 (7.1%) | 0 (0.0%) | 4 (4.6%) | 4 (4.2%) | 16 (4.6%) |
| GDI | 0 (0.0%) | 4 (7.1%) | 2 (3.6%) | 5 (5.7%) | 0 (0.0%) | 11 (3.2%) |
| Total | 461 | 477 | 669 | 754 | 714 | 3075 |
PACG = primary angle-closure glaucoma, POAG = primary open-angle glaucoma, Phaco = phacoemulsification, Phaco-trab = phacotrabeculectomy, Trab = trabeculectomy, LPI = laser peripheral iridectomy, TSCP = transscleral diode laser cyclophotocoagulation, and GDI = glaucoma drainage implant.
Changes in IOP after different surgical methods for primary glaucoma (M, mmHg).
| Preoperative IOP | Postoperative IOP | IOP difference |
|
| |
|---|---|---|---|---|---|
| PACG | |||||
| Phaco | 18.5 | 13.0 | 4.0 | −14.5 | <0.001 |
| Phaco-trab | 32.0 | 13.0 | 18.0 | −27.8 | <0.001 |
| Trab | 43.0 | 13.0 | 27.0 | −23.7 | <0.001 |
| LPI | 61.0 | 11.0 | 49.5 | −7.4 | <0.001 |
| TSCP | 46.1 | 17.0 | 29.5 | −9.4 | <0.001 |
| POAG | |||||
| Phaco-trab | 22.0 | 16.0 | 7.0 | −10.2 | <0.001 |
| Trab | 29.0 | 14.0 | 15.0 | −8.6 | <0.001 |
| TSCP | 32.5 | 18.0 | 14.5 | −3.5 | 0.001 |
| GDI | 33.0 | 9.0 | 27.0 | −2.9 | 0.003 |
IOP = intraocular pressure, PACG = primary angle-closure glaucoma, POAG = primary open-angle glaucoma, Phaco = phacoemulsification, Phaco-trab = phacotrabeculectomy, Trab = trabeculectomy, LPI = laser peripheral iridectomy, TSCP = transscleral diode laser cyclophotocoagulation, and GDI = glaucoma drainage implant.
Changes in VA after different surgical methods for primary glaucoma.
| Preoperative VA | Postoperative VA |
|
| |||||
|---|---|---|---|---|---|---|---|---|
| <0.05 | ≥0.05 and <0.3 | ≥0.3 | <0.05 | ≥0.05 and <0.3 | ≥0.3 | |||
| PACG | ||||||||
| Phaco | 189 | 255 | 147 | 79 | 227 | 285 | −11.5 | <0.001 |
| Phaco-trab | 331 | 459 | 353 | 177 | 488 | 478 | −10.3 | <0.001 |
| Trab | 257 | 213 | 334 | 82 | 307 | 415 | −11.5 | <0.001 |
| LPI | 32 | 19 | 21 | 6 | 10 | 56 | −5.7 | <0.001 |
| TSCP | 104 | 13 | 3 | 97 | 16 | 7 | −2.1 | 0.032 |
| POAG | ||||||||
| Phaco-trab | 47 | 101 | 57 | 26 | 64 | 115 | −6.7 | <0.001 |
| Trab | 17 | 34 | 62 | 11 | 34 | 68 | −1.9 | 0.058 |
| TSCP | 12 | 4 | 0 | 11 | 5 | 0 | −0.6 | 0.564 |
| GDI | 2 | 3 | 6 | 2 | 4 | 5 | −0.4 | 0.655 |
VA = visual acuity, PACG = primary angle-closure glaucoma, POAG = primary open-angle glaucoma, Phaco = phacoemulsification, Phaco-trab = phacotrabeculectomy, Trab = trabeculectomy, LPI = laser peripheral iridectomy, TSCP = transscleral diode laser cyclophotocoagulation, and GDI = glaucoma drainage implant.